Denver Investment Advisors’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-14,032
Closed -$419K 500
2015
Q4
$419K Buy
14,032
+797
+6% +$26.9K 0.02% 360
2015
Q3
$417K Sell
13,235
-532
-4% -$26K 0.02% 363
2015
Q2
$666K Sell
13,767
-35,931
-72% -$1.51M 0.02% 339
2015
Q1
$2.15M Sell
49,698
-17,086
-26% -$614K 0.07% 269
2014
Q4
$1.76M Buy
+66,784
New +$1.46M 0.06% 293

Other funds holding PGEN

Denver Investment Advisors's PGEN Position: Q1 2016 in Review

Denver Investment Advisors sold out of Precigen (PGEN) in Q1 2016, closing a stake of 14,032 shares — an estimated $419K sold.

Denver Investment Advisors first reported a position in PGEN in Q4 2014 and held it in 5 quarters. The position peaked at $2.15M in Q1 2015. 191 funds tracked by Wall St. Rank hold PGEN as of Q1 2016.

  • Denver Investment Advisors reported no remaining Precigen position as of Q1 2016 after selling out during the quarter.
  • Denver Investment Advisors sold 14,032 Precigen shares in Q1 2016, an estimated $419K.
  • Denver Investment Advisors first reported a position in Precigen in Q4 2014 and held it in 5 quarters.
  • Denver Investment Advisors's Precigen position peaked at $2.15M in Q1 2015.
  • 191 funds tracked by Wall St. Rank held Precigen as of Q1 2016.

Based on Denver Investment Advisors's 13F filing for Q1 2016, filed 12 May 2016.